Songdo Convensia Phase 3 Expansion Planned Amid High Demand Incheon Authority to Proceed With Phase 3 as Utilization Nears 60 ...

Accelerated Phase 3 CoMpass Enrollment Supports Mid-2026 Enrollment Completion and 2H 2027 Topline Data GuidancePhase 1b/2 NMIBC Trial on Track: ...

Envudeucitinib achieved robust PASI responses by Week 16, with significant continued improvements by Week 24 in PASI 90 (68.0%, 62.1%) and PASI ...

Three undervalued Dividend Aristocrats we identified a year ago have delivered positive returns since. Three new picks also ...

Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for serious and rare diseases, today ...

Base outlines its 2026 roadmap focused on global markets, stablecoins, and builders as it expands its onchain economy ...

Returning to the moon and building a base will pale in comparison to what we will be capable of accomplishing in the years ...

Dr. Jennifer Buell (President, CEO & Director) reiterated MiNK’s differentiation as “an off the shelf” allogeneic iNKT platform that is “administered without lymphodepletion, without HLA matching,” ...

ALPENA — Alpena Public Schools hosted a second “Reimagine our Future” community forum on Tuesday night, when representatives ...

By Valentina Za MILAN, March 24 (Reuters) - Banca Monte dei Paschi di Siena said its board had chosen Fabrizio Palermo as its ...

NASA's Artemis II astronauts launched on a nine-and-a-half-day mission around the moon and back. Follow live updates.

The COVID-19 vaccine boom made fortunes almost overnight—and destroyed them just as fast. Moderna (NASDAQ: MRNA) has fallen 58.2% over five years. BioNTech (NASDAQ: BNTX) is down 10.9% over the same ...